Evidence for increased activity of mouse brain fatty acid cyclooxygenase following drug-induced convulsions.
Enzymatic production of prostaglandins (PGs) from exogenous arachidonic acid was studied in brain microsomal fractions prepared from mice following pentylenetetrazol (PTZ)-induced convulsions. Prostaglandin E2 (PGE2) and prostaglandin F2 alpha (PGF2 alpha) measured either by radioimmunoassay or after incubation with [1-14C]arachidonic acid (AA) was significantly increased in microsomes from the convulsed animals. Pretreatment of the mice with the anticonvulsant ethosuximide prevented the enhanced PG production. The increased PG synthesis could not be attributed to an increased substrate availability nor to an activated phospholipase nor to a direct effect of the convulsant on the fatty acid cyclooxygenase. Evidence that a modification of the cyclooxygenase had occurred with seizure activity was obtained from kinetic analysis; the apparent Km for the AA was lowered from 30 +/- 3 microM in the controls to 12 +/- 1 microM in the PTZ-treated mice. Further evidence for a modification of the fatty acid cyclooxygenase was obtained from incubations of the microsomes with catalase to reduce peroxide formation. Limiting peroxide levels did not decrease the microsomal cyclooxygenase activity in the PTZ-treated mice to control levels. Seizure activity induced by picrotoxin and strychnine also increased the microsomal capacity of the convulsed animals to synthesize PGs. The increased brain fatty acid cyclooxygenase activity may result from a biochemical modification of the enzyme induced by seizure activity.
D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism; D001921:Brain / Q000187:drug effects / Q000201:enzymology*; D015237:Dinoprost; D015232:Dinoprostone; D005013:Ethosuximide / Q000494:pharmacology; D005260:Female; D007700:Kinetics; D051379:Mice; D008861:Microsomes / Q000201:enzymology; D010433:Pentylenetetrazole; D010852:Picrotoxin / Q000494:pharmacology; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism*; D011458:Prostaglandins E / Q000378:metabolism*; D011460:Prostaglandins F / Q000378:metabolism*; D012640:Seizures / Q000139:chemically induced / Q000201:enzymology*; D013331:Strychnine / Q000494:pharmacology
D016718:Arachidonic Acid; D001095:Arachidonic Acids; D015237:Dinoprost; D015232:Dinoprostone; D005013:Ethosuximide; D010433:Pentylenetetrazole; D010852:Picrotoxin; D011451:Prostaglandin-Endoperoxide Synthases; D011458:Prostaglandins E; D011460:Prostaglandins F; D013331:Strychnine